Definitive Contract 75F40120C00174
Award Date
9/28/20
Potential Completion Date
9/28/24
Potential Value
$3.3M
Federal Agency
Food and Drug Administration
Awardee
Yale Univ
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Hamden, CT 06511, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $250,000.00 firm fixed price purchase order contract to Yale University, a private non-profit educational institution, to collect pathologist annotations. The contract has a completion date of September 28, 2027 and was awarded on September 28, 2022. The contract does not have a set-aside designation. As a prime contractor for federal agencies, Yale University has experience providing research,...
The Department of Health and Human Services Food and Drug Administration awarded a $249,999.00 definitive contract to Hartford Hospital, a non-profit hospital organization, to conduct research and development in support of regulatory science and innovation. This contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science for fiscal year 2021, which solicits proposals across eight areas of regulatory science to modernize FDA functions. The contract does not...
The University of Connecticut Office of Sponsored Programs Division was awarded a definitive contract valued at approximately $973,184 by the Department of Health and Human Services' Food and Drug Administration. The contract is for a study to assess the impact of polymer attributes on the performance of in situ forming implants. The prime contractor will conduct the research over a three-year period of performance ending in September 2023. As the prime, the University of Connecticut will...
This is a $99,932 firm fixed-price purchase order awarded by the National Cancer Institute, part of the Department of Health and Human Services, to Yale University to conduct research on exploring Medicare Part D claims data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare Health Outcomes Survey (MHOS). The contract has an ultimate completion date of November 21, 2018 and does not have a set-aside designation. Yale University is the prime contractor for this work and has a...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $252,340.80 firm fixed price contract to Yale University, a private non-profit university, for Health Equity Consulting Support related to the COVID-19 pandemic. The contract was awarded on May 14, 2021 with a period of performance through May 13, 2022. No set-aside was used for this contract. As a leading research institution, Yale University has experience providing...
Duke University Office of Research Administration Division was awarded a $274,413 definitive contract by the Department of Health and Human Services Food and Drug Administration to conduct a study using electronic health records to identify and assess adverse events for biologic therapies. The contract aims to develop and validate methodological approaches under the agency's Broad Agency Announcement for the Advanced Research and Development of Regulatory Science, which seeks proposals to...
This is a $414,315 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University, a private research university, to assess the contamination and survivability of SARS-CoV-2 on surfaces. The contract, which has a period of performance through September 27, 2022, was awarded on September 28, 2020 and is designated as related to the Coronavirus COVID-19 national interest action. No set-aside was used for this award. Yale University is registered in...
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
The Department of Health and Human Services Food and Drug Administration awarded a definitive contract valued at $82.2 million to the Massachusetts Institute of Technology under Broad Agency Announcement FY22 FDA BAA for Advanced Research and Development of Regulatory Science. The contract supports the development of an integrated continuous cGMP facility for mRNA manufacturing to address the solicitation's goal of advancing regulatory science tools and approaches for safety and quality...
The Department of Health and Human Services Food and Drug Administration awarded a $350,000 definitive cost-no-fee contract to Elligo Health Research, Inc. to support the agency's Broad Agency Announcement seeking proposals to extend the value of common data model harmonization in generating clinical evidence from real world data sufficient to support regulatory use. The small disadvantaged business will perform work at locations in Silver Spring, Maryland under the contract addressing the...